# ADR-006: Temporal Epigenomic & Lifespan Analysis Engine

**Status**: Proposed
**Date**: 2026-02-11
**Authors**: ruv.io, RuVector DNA Analyzer Team
**Deciders**: Architecture Review Board
**Target Crates**: `ruvector-temporal-tensor`, `ruvector-nervous-system`, `sona`, `ruvector-delta-core`

## Version History

| Version | Date | Author | Changes |
|---------|------|--------|---------|
| 0.1 | 2026-02-11 | RuVector DNA Analyzer Team | Initial proposal |

---

## Context and Problem Statement

### The Epigenomic Temporal Challenge

The epigenome -- the totality of chemical modifications that regulate gene expression without altering the underlying DNA sequence -- is not static. It changes continuously throughout an organism's lifespan in response to development, aging, environmental exposure, disease, and therapeutic intervention. These changes span three principal categories:

1. **DNA methylation**: The addition of methyl groups (-CH3) to the 5-carbon position of cytosine residues, predominantly at CpG dinucleotides. The human genome contains approximately 28 million CpG sites, of which 60-80% are methylated in any given tissue. Methylation at gene promoters (CpG islands) silences transcription; methylation at gene bodies correlates with active transcription.

2. **Histone modifications**: Post-translational covalent modifications to histone tail residues. The combinatorial pattern of modifications -- the "histone code" -- determines chromatin state and transcriptional competence:

   | Mark | Residue | Function | Genomic Location |
   |------|---------|----------|-----------------|
   | H3K4me3 | Histone H3, Lysine 4, trimethylation | Active promoter | TSS +/- 2 kbp |
   | H3K4me1 | Histone H3, Lysine 4, monomethylation | Poised/active enhancer | Distal regulatory elements |
   | H3K27ac | Histone H3, Lysine 27, acetylation | Active enhancer/promoter | TSS and distal enhancers |
   | H3K27me3 | Histone H3, Lysine 27, trimethylation | Polycomb-mediated repression | Silenced developmental genes |
   | H3K36me3 | Histone H3, Lysine 36, trimethylation | Active gene body | Exonic regions of transcribed genes |
   | H3K9me3 | Histone H3, Lysine 9, trimethylation | Constitutive heterochromatin | Pericentromeric repeats, retrotransposons |
   | H3K9ac | Histone H3, Lysine 9, acetylation | Active transcription | Promoters and enhancers |
   | H4K20me3 | Histone H4, Lysine 20, trimethylation | Heterochromatin / DNA damage | Repetitive elements, damage foci |
   | H2AK119ub1 | Histone H2A, Lysine 119, ubiquitination | Polycomb-mediated repression | PRC1 target genes |

3. **Chromatin accessibility**: The physical openness of chromatin, measured by ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) or DNase-seq. Open chromatin regions (~2-3% of the genome at any time) correspond to active regulatory elements -- promoters, enhancers, insulators, and silencers.

### Why Temporal Modeling Is Hard

Existing epigenomic analysis tools treat each time point as an independent snapshot. They lack the mathematical machinery to model:

| Challenge | Current State | Consequence |
|-----------|--------------|-------------|
| Temporal continuity | Each ChIP-seq/bisulfite-seq sample analyzed independently | Cannot detect gradual epigenetic drift (e.g., age-related CpG island hypermethylation accumulating at 0.1-0.5% per year) |
| Multi-scale dynamics | Fixed time resolution | Cannot simultaneously model rapid changes (histone acetylation, minutes to hours) and slow changes (DNA methylation, months to years) |
| Cell-type deconvolution over time | Static deconvolution per sample | Cannot track cell-type proportion changes (e.g., loss of naive T cells with aging, clonal hematopoiesis expansion) |
| Cross-tissue correlation | Per-tissue analysis | Cannot detect systemic epigenetic aging signatures that manifest across tissues (e.g., the Horvath multi-tissue clock) |
| Sparse observations | Requires dense sampling | Longitudinal studies typically have 2-10 time points per individual; interpolation between observations is unsupported |

### Epigenetic Clock Limitations

The Horvath multi-tissue clock (2013) demonstrated that DNA methylation at 353 CpG sites predicts chronological age with a median absolute deviation of 3.6 years across 51 tissues. Since then, numerous clocks have been developed:

| Clock | CpG Sites | Training Tissue | Metric Predicted | Limitation |
|-------|-----------|----------------|-----------------|------------|
| Horvath (2013) | 353 | Multi-tissue (51 types) | Chronological age | No disease-specific acceleration |
| Hannum (2013) | 71 | Blood | Chronological age | Blood-only; tissue-specific bias |
| Levine/PhenoAge (2018) | 513 | Blood | Phenotypic age (mortality risk) | No mechanistic decomposition |
| Lu/GrimAge (2019) | 1,030 | Blood | Mortality-adjusted age | Requires plasma protein proxies |
| DunedinPACE (2022) | 173 | Blood | Pace of aging (years/year) | Requires longitudinal calibration |
| Skin&Blood clock (2018) | 391 | Skin + blood | Chronological age | Limited tissue scope |
| Pediatric clock (2019) | 94 | Blood (pediatric) | Gestational/developmental age | Not validated in adults |

None of these clocks provides:
- Real-time tracking of epigenetic age acceleration during disease or treatment
- Decomposition of aging into component processes (e.g., inflammatory, metabolic, replicative)
- Integration of histone modification and chromatin accessibility data alongside methylation
- Patient-specific adaptation that learns individual epigenetic trajectories

### RuVector Advantages

RuVector provides the computational substrate required for temporal epigenomic analysis:

- **`ruvector-temporal-tensor`**: 4D sparse tensor algebra with temporal indexing, delta-compressed storage, and streaming decomposition -- designed for genomic data that is vast in genome position but sparse in observation time
- **`ruvector-nervous-system`**: Spiking neural network (SNN) engine with biologically inspired Hebbian learning, neuromodulatory signal integration, and spike-timing-dependent plasticity (STDP) -- suited for detecting temporal patterns in irregularly sampled biological signals
- **`sona`** (Self-Optimizing Neural Architecture): Real-time architecture adaptation with <0.05ms latency, continuous learning from patient-specific data without catastrophic forgetting (EWC++ protection)
- **`ruvector-delta-core`**: Delta-encoded storage engine optimized for time-series genomic data where consecutive observations differ by <1% of values, achieving 50-200x compression over raw storage

---

## Decision

### Adopt a 4D Temporal Tensor Architecture for Lifespan Epigenomic Analysis

We implement a temporal epigenomic engine that represents the full epigenomic state as a 4-dimensional tensor, decomposes it for efficient storage and query, integrates spiking neural networks for biological pattern detection, and self-optimizes to each patient's epigenomic trajectory via SONA. The system supports real-time streaming of new epigenomic observations and provides clinically actionable outputs including biological age estimation, disease risk prediction, and intervention response tracking.

---

## Temporal Tensor Design

### 4D Tensor Structure

The core data structure is a 4-dimensional tensor T representing the complete epigenomic state:

```
T[g, m, c, t] in R

where:
  g in {1, ..., G}    -- genome position index (G ~ 28,000,000 CpG sites for methylation;
                          G ~ 15,500,000 200bp windows for histone marks)
  m in {1, ..., M}    -- epigenetic mark index (M ~ 12-20 marks)
  c in {1, ..., C}    -- cell type index (C ~ 50-200 distinct cell types)
  t in {1, ..., T_max} -- time index (discretized to observation time points)
```

**Axis definitions:**

| Axis | Symbol | Cardinality | Resolution | Source Assay |
|------|--------|-------------|------------|-------------|
| Genome position (g) | G | 28M (CpG sites) or 15.5M (200bp windows) | Single CpG or 200bp bin | WGBS, RRBS, ChIP-seq, ATAC-seq |
| Epigenetic mark (m) | M | 12-20 | Per-mark channel | See mark table below |
| Cell type (c) | C | 50-200 | Per-cell-type deconvolution | Computational deconvolution or single-cell |
| Time (t) | T_max | 2-1000 per patient | Irregular, event-driven | Longitudinal sampling |

**Mark channels (m axis):**

| Index | Mark | Value Range | Biological Meaning |
|-------|------|-------------|-------------------|
| 0 | CpG methylation (5mC) | [0.0, 1.0] | Beta value: fraction of methylated CpGs in the window |
| 1 | CpG hydroxymethylation (5hmC) | [0.0, 1.0] | Active demethylation intermediate (TET-mediated) |
| 2 | H3K4me3 | [0.0, +inf) | Normalized ChIP-seq signal; active promoter |
| 3 | H3K4me1 | [0.0, +inf) | Normalized ChIP-seq signal; poised/active enhancer |
| 4 | H3K27ac | [0.0, +inf) | Normalized ChIP-seq signal; active enhancer/promoter |
| 5 | H3K27me3 | [0.0, +inf) | Normalized ChIP-seq signal; Polycomb repression |
| 6 | H3K36me3 | [0.0, +inf) | Normalized ChIP-seq signal; active gene body |
| 7 | H3K9me3 | [0.0, +inf) | Normalized ChIP-seq signal; heterochromatin |
| 8 | H3K9ac | [0.0, +inf) | Normalized ChIP-seq signal; active transcription |
| 9 | H4K20me3 | [0.0, +inf) | Normalized ChIP-seq signal; heterochromatin/damage |
| 10 | ATAC-seq | [0.0, +inf) | Normalized Tn5 insertion count; chromatin accessibility |
| 11 | CTCF binding | [0.0, +inf) | Normalized ChIP-seq signal; insulator/TAD boundary |
| 12 | CpG density | [0.0, 1.0] | Static: fraction of CpG dinucleotides in window (invariant over time) |
| 13 | GC content | [0.0, 1.0] | Static: GC fraction in window (invariant over time) |

### Sparse Temporal Representation

The 4D tensor is extremely sparse along every axis:

- **Genome axis**: Of 28M CpG sites, only ~450,000 are measured by Illumina EPIC array (the most common clinical methylation platform); WGBS covers all 28M but at high cost
- **Mark axis**: A typical experiment measures 1-6 marks, not all 14
- **Cell type axis**: Bulk tissue contains a mixture of cell types; deconvolution estimates proportions but individual cell-type signals are noisy
- **Time axis**: Longitudinal cohorts have 2-10 time points per patient; dense temporal sampling is rare

**Sparsity analysis:**

| Scenario | Tensor Dimensions | Dense Size | Observed Entries | Sparsity | Sparse Size |
|----------|-------------------|-----------|-----------------|----------|-------------|
| EPIC array, blood, 5 time points | 450K x 1 x 1 x 5 | 8.6 MB | 2.25M | 0% (dense on measured CpGs) | 8.6 MB |
| WGBS + 6 histone marks, blood, 10 time points | 28M x 7 x 1 x 10 | 7.3 GB | ~200M (non-zero) | 89.8% | 760 MB |
| Multi-tissue (12 tissues), EPIC, 20 time points | 450K x 1 x 12 x 20 | 412 MB | ~108M | 0% | 412 MB |
| Single-cell ATAC + methylation, 50 cell types, 5 time points | 15.5M x 2 x 50 x 5 | 28.9 GB | ~500M | 96.8% | 1.9 GB |
| Full multi-omic, 200 cell types, 100 time points | 28M x 14 x 200 x 100 | 14.6 TB | ~2B | 99.997% | 7.6 GB |

The coordinate-list (COO) sparse format stores only non-zero entries as `(g, m, c, t, value)` tuples. At 20 bytes per entry (4 bytes each for g, m, c, t indices + 4 bytes for f32 value), 2 billion entries require 40 GB in raw COO format. With delta encoding (see below), this compresses to approximately 7.6 GB.

### Delta Encoding via `ruvector-delta-core`

Epigenomic states change slowly between consecutive observations. For DNA methylation, the typical per-CpG change between annual observations is:

```
|beta(t+1) - beta(t)| < 0.01 for >95% of CpG sites
|beta(t+1) - beta(t)| < 0.05 for >99.5% of CpG sites
```

This makes delta encoding highly effective. `ruvector-delta-core` stores:

1. **Base frame** (t=0): Full sparse tensor at the first observation time point
2. **Delta frames** (t=1, 2, ...): Only entries that changed beyond a configurable epsilon threshold

```
Delta(t) = {(g, m, c, T[g,m,c,t] - T[g,m,c,t-1]) : |T[g,m,c,t] - T[g,m,c,t-1]| > epsilon}
```

**Compression ratios by data type:**

| Data Type | Epsilon | Changed Entries per Time Step | Delta Size vs Full Frame | Cumulative Compression |
|-----------|---------|------------------------------|-------------------------|----------------------|
| DNA methylation (annual) | 0.005 | ~5% of CpG sites | 20:1 | 50-100x over raw |
| DNA methylation (weekly, during treatment) | 0.002 | ~15% of CpG sites | 6.7:1 | 20-50x over raw |
| H3K27ac (response to stimulus, hourly) | 0.01 | ~30% of peaks | 3.3:1 | 10-20x over raw |
| ATAC-seq (developmental transition) | 0.01 | ~40% of peaks | 2.5:1 | 8-15x over raw |
| H3K9me3 (constitutive heterochromatin, annual) | 0.01 | ~0.5% of regions | 200:1 | 500-1000x over raw |

**Delta storage format:**

```rust
/// Delta frame: changes from the previous time point
pub struct DeltaFrame {
    /// Time index of this frame
    pub time_index: u32,

    /// Absolute timestamp (seconds since epoch)
    pub timestamp: i64,

    /// Changed entries: (genome_pos, mark, cell_type, delta_value)
    /// Sorted by (genome_pos, mark, cell_type) for binary search
    pub deltas: Vec<DeltaEntry>,

    /// Checksum for integrity verification
    pub checksum: u64,
}

pub struct DeltaEntry {
    /// Genome position index (varint-encoded, typically 1-3 bytes due to locality)
    pub genome_pos: u32,

    /// Epigenetic mark index (4 bits, packed with cell_type)
    pub mark: u8,

    /// Cell type index (12 bits, packed with mark into 2 bytes)
    pub cell_type: u16,

    /// Delta value: T[g,m,c,t] - T[g,m,c,t-1]
    /// Quantized to i16 for methylation (range [-1.0, 1.0] mapped to [-32768, 32767])
    /// or f16 for ChIP-seq signal deltas
    pub delta: DeltaValue,
}

pub enum DeltaValue {
    /// Methylation beta-value delta, quantized to i16 (precision: ~3e-5)
    MethylationDelta(i16),

    /// ChIP-seq signal delta, stored as f16 (IEEE 754 half-precision)
    SignalDelta(f16),

    /// Binary accessibility change (ATAC-seq: open->closed or closed->open)
    AccessibilityFlip(bool),
}
```

### Tensor Decomposition

For queries spanning large genomic regions or multiple cell types, direct access to the sparse tensor is inefficient. We decompose T using a temporal extension of Tucker decomposition:

```
T[g, m, c, t] ~ sum_{r1=1}^{R1} sum_{r2=1}^{R2} sum_{r3=1}^{R3} sum_{r4=1}^{R4}
    G_core[r1, r2, r3, r4] * U_genome[g, r1] * U_mark[m, r2] * U_cell[c, r3] * U_time[t, r4]
```

Where:
- `G_core` is the core tensor of size `R1 x R2 x R3 x R4` (typically 100 x 10 x 20 x 50)
- `U_genome` (G x R1) captures principal genomic patterns (e.g., CpG island vs. gene body vs. enhancer)
- `U_mark` (M x R2) captures mark co-occurrence patterns (e.g., H3K4me3+H3K27ac = active promoter)
- `U_cell` (C x R3) captures cell-type programs (e.g., immune cell signature, neuronal signature)
- `U_time` (T_max x R4) captures temporal dynamics (e.g., aging trajectory, treatment response curve)

**Decomposition ranks and storage:**

| Factor | Dimensions | Rank | Storage |
|--------|-----------|------|---------|
| U_genome | 28M x 100 | R1 = 100 | 10.4 GB (f32) |
| U_mark | 14 x 10 | R2 = 10 | 560 B |
| U_cell | 200 x 20 | R3 = 20 | 16 KB |
| U_time | 1000 x 50 | R4 = 50 | 200 KB |
| G_core | 100 x 10 x 20 x 50 | -- | 3.8 MB |
| **Total decomposed** | | | **~10.4 GB** |

The decomposition enables answering temporal queries without reconstructing the full tensor:

```
"What is the methylation trajectory of the BRCA1 promoter in CD8+ T cells?"
  -> Look up genome positions for BRCA1 promoter CpG island (chr17:43,125,270-43,125,483)
  -> Extract U_genome rows for those positions
  -> Extract U_cell column for CD8+ T cells
  -> Extract U_mark column for 5mC methylation
  -> Reconstruct temporal signal via: signal(t) = sum over ranks of core * factors
  -> Return time series with R4=50 time basis functions
```

**Streaming decomposition update:** When new observations arrive, the factor matrices are updated incrementally using online Tucker decomposition (Kasiviswanathan et al., 2011). The update cost per new time point is O(G * R1 + R1 * R2 * R3 * R4), dominated by the genome factor update. For G=28M and R1=100, this takes approximately 200ms on a single core -- well within the streaming latency budget.

### Temporal Query Algebra

`ruvector-temporal-tensor` exposes a query algebra for temporal epigenomic operations:

```rust
use ruvector_temporal_tensor::{TemporalTensor, TimeRange, TemporalQuery, AggregationOp};

// Query 1: Methylation trajectory at specific locus
let query = TemporalQuery::new()
    .genome_range(43_125_270..43_125_483)    // BRCA1 promoter CpG island
    .marks(&[Mark::CpG5mC])                  // DNA methylation only
    .cell_types(&[CellType::CD8T])            // CD8+ T cells
    .time_range(TimeRange::All)               // Full lifespan
    .aggregate(AggregationOp::MeanOverGenome) // Average across CpG sites in region
    .build();

let trajectory: TimeSeries = tensor.query(&query)?;
// Returns: Vec<(timestamp, mean_methylation_beta)>

// Query 2: Bivalent promoter dynamics during differentiation
let bivalent_query = TemporalQuery::new()
    .genome_predicate(|g| is_promoter(g) && is_cpg_island(g))
    .marks(&[Mark::H3K4me3, Mark::H3K27me3])   // Bivalent marks
    .cell_types(&[CellType::HSC, CellType::Monocyte])
    .time_range(TimeRange::Between(day_0, day_14))
    .build();

let bivalent_dynamics: SparseTemporalSlice = tensor.query(&bivalent_query)?;

// Query 3: Genome-wide methylation drift rate
let drift_query = TemporalQuery::new()
    .genome_range(0..28_000_000)              // All CpG sites
    .marks(&[Mark::CpG5mC])
    .cell_types(&[CellType::WholeBlood])
    .time_range(TimeRange::All)
    .aggregate(AggregationOp::TemporalDerivative) // d(methylation)/dt
    .build();

let drift_rates: GenomeWideRates = tensor.query(&drift_query)?;
// Returns: per-CpG methylation drift rate (beta-value units per year)
```

---

## Epigenetic Clock Architecture

### Multi-Tissue Age Estimation

The temporal tensor enables a unified epigenetic clock that operates across all tissues simultaneously, rather than requiring tissue-specific training. The architecture:

```
                         Temporal Tensor T[g, m, c, t]
                                    |
                    +---------------+---------------+
                    |               |               |
                    v               v               v
           +-------+------+ +------+------+ +------+------+
           | Methylation  | | Histone     | | Chromatin   |
           | Clock Module | | Clock Module| | Clock Module|
           | (CpG sites)  | | (ChIP peaks)| | (ATAC peaks)|
           +-------+------+ +------+------+ +------+------+
                    |               |               |
                    v               v               v
           +-------+------+ +------+------+ +------+------+
           | 1,030 CpG    | | 500 histone | | 300 ATAC    |
           | features     | | features    | | features    |
           | (GrimAge     | | (bivalent   | | (accessibility|
           |  extended)   | |  dynamics)  | |  decay rate) |
           +-------+------+ +------+------+ +------+------+
                    |               |               |
                    +-------+-------+-------+-------+
                            |
                            v
                   +--------+--------+
                   | Multi-Modal     |
                   | Fusion Layer    |
                   | (attention-     |
                   |  weighted)      |
                   +--------+--------+
                            |
            +---------------+---------------+
            |               |               |
            v               v               v
    +-------+------+ +-----+------+ +------+------+
    | Chronological| | Biological | | Pace of     |
    | Age          | | Age        | | Aging       |
    | Estimator    | | Estimator  | | Estimator   |
    +-------+------+ +-----+------+ +------+------+
            |               |               |
            v               v               v
      Age (years)   Bio-Age (years)   Rate (years/year)
                            |
                            v
                   +--------+--------+
                   | Age Acceleration |
                   | = Bio-Age -     |
                   |   Chrono-Age    |
                   +--------+--------+
                            |
                   +--------v--------+
                   | Disease-Specific|
                   | Decomposition   |
                   +-----------------+
```

### Biological vs. Chronological Age

The engine computes three age metrics:

**1. Chronological Age Estimate (DNAmAge)**

Elastic net regression on the methylation beta-values of 1,030 CpG sites (extending GrimAge with temporal features):

```
DNAmAge = intercept + sum_{i=1}^{1030} w_i * beta_i + sum_{j=1}^{50} v_j * temporal_feature_j
```

Where temporal features include:
- Per-CpG methylation velocity: `d(beta_i)/dt` estimated from the temporal tensor
- Per-CpG methylation acceleration: `d^2(beta_i)/dt^2`
- Cross-CpG correlation change rate: `d(corr(beta_i, beta_j))/dt` for the top 50 most correlated CpG pairs
- Cell-type proportion change rates: `d(fraction_c)/dt` for the 6 major blood cell types

**2. Biological Age Estimate (PhenoAge-Temporal)**

A Cox proportional hazards model trained on mortality outcomes, incorporating both static methylation features and temporal dynamics:

```
h(t) = h_0(t) * exp(X * beta_pheno)
```

Where `X` includes:
- 513 PhenoAge CpG beta-values
- 10 methylation-derived plasma protein surrogates (from GrimAge)
- 50 temporal velocity features
- Blood cell-type composition change rates
- Methylation entropy (Shannon entropy across CpG sites, measuring epigenetic disorder)

**3. Pace of Aging (DunedinPACE-Temporal)**

An instantaneous rate of biological aging measured in biological years per chronological year:

```
PaceOfAging(t) = d(BioAge) / d(ChronoAge)
    = (BioAge(t + delta) - BioAge(t - delta)) / (2 * delta)
```

Where delta is the smallest available time interval. Values:
- PaceOfAging = 1.0: Aging at the expected rate
- PaceOfAging > 1.0: Accelerated aging
- PaceOfAging < 1.0: Decelerated aging (observed during caloric restriction interventions and some pharmacological treatments)

### Disease-Specific Aging Signatures

The biological age acceleration (BioAge - ChronoAge) is decomposed into component processes using non-negative matrix factorization (NMF) on the CpG-level age-deviation tensor:

```
Deviation[g, patient] ~ W[g, k] * H[k, patient]

where:
  g = CpG site index
  k = aging component (k = 1, ..., K; typically K = 8-12)
  W[g, k] = contribution of CpG g to aging component k
  H[k, patient] = intensity of aging component k in this patient
```

Empirically derived aging components and their clinical associations:

| Component | Top CpG Regions | Associated Pathway | Clinical Association |
|-----------|----------------|-------------------|---------------------|
| k=1 (Inflammatory) | IL6 promoter, TNF regulatory region, NF-kB targets | Chronic inflammation | Cardiovascular disease, rheumatoid arthritis |
| k=2 (Metabolic) | IGF1 gene body, FOXO3 promoter, mTOR pathway genes | Insulin/IGF-1 signaling | Type 2 diabetes, metabolic syndrome |
| k=3 (Replicative) | Telomere-adjacent CpGs, TERT promoter | Replicative senescence | Cancer risk, bone marrow failure |
| k=4 (Immunosenescent) | CD8A/B, IFNG, GZMB regulatory regions | Immune exhaustion | Infection susceptibility, vaccine response |
| k=5 (Polycomb erosion) | H3K27me3-marked developmental genes (HOX clusters, PAX, SOX) | Polycomb maintenance | Neurodegeneration, developmental gene reactivation |
| k=6 (Mitochondrial) | Nuclear-encoded mitochondrial gene promoters (NDUFB, COX, ATP5) | Mitochondrial dysfunction | Parkinson disease, sarcopenia |
| k=7 (Epigenetic maintenance) | DNMT1, DNMT3A, DNMT3B, TET1/2/3 regulatory regions | DNA methylation machinery | Global hypomethylation, cancer predisposition |
| k=8 (Stochastic drift) | Random CpG sites with high inter-individual variance | Epigenetic noise | General aging, cellular heterogeneity |

### Intervention Tracking

The temporal tensor enables quantitative tracking of epigenetic age interventions:

```rust
use ruvector_temporal_tensor::clock::{EpigeneticClock, InterventionTracker};

let clock = EpigeneticClock::multi_tissue();
let tracker = InterventionTracker::new(&clock);

// Record baseline measurement
tracker.add_observation(patient_id, time_baseline, &methylation_array_baseline)?;

// Record post-intervention measurements
tracker.add_observation(patient_id, time_post_6mo, &methylation_array_6mo)?;
tracker.add_observation(patient_id, time_post_12mo, &methylation_array_12mo)?;

// Compute intervention effect
let effect = tracker.compute_effect(patient_id)?;
// InterventionEffect {
//     delta_bio_age: -2.3,           // Biological age decreased by 2.3 years
//     delta_pace: -0.15,             // Pace of aging decreased by 0.15 years/year
//     component_effects: {
//         inflammatory: -0.8,         // Inflammatory aging component decreased most
//         metabolic: -0.5,
//         polycomb_erosion: -0.3,
//         ...,
//     },
//     confidence_interval_95: (-3.1, -1.5),
//     p_value: 0.002,                // Statistical significance of the observed change
//     effect_trajectory: TimeSeries,  // How the effect evolved over the 12-month period
// }
```

**Clinical intervention tracking targets:**

| Intervention | Expected Effect on BioAge | Monitoring Interval | Key CpG Regions |
|-------------|--------------------------|--------------------|--------------------|
| Caloric restriction (25%) | -1.5 to -3.0 years after 2 years | 3-6 months | IGF1, mTOR pathway, FOXO3 |
| Metformin (longevity dose) | -0.5 to -1.5 years after 1 year | 6 months | AMPK targets, NF-kB pathway |
| Senolytics (dasatinib + quercetin) | -0.5 to -2.0 years after 6 months | 3 months | CDKN2A (p16), senescence-associated CpGs |
| Exercise (150 min/week moderate) | -0.3 to -1.0 years after 1 year | 6-12 months | PGC1A, PPARG, mitochondrial genes |
| Epigenetic reprogramming (partial) | -5 to -15 years (experimental) | 1-3 months | Yamanaka factor targets (OCT4, SOX2, KLF4, MYC) |

---

## Nervous System Model (ruvector-nervous-system)

### Spiking Neural Networks for Temporal Epigenomic Patterns

Conventional artificial neural networks (ANNs) process data in discrete forward passes with static activations. Biological neural networks process information through the precise timing of discrete electrical impulses (spikes). For temporal epigenomic data, spiking neural networks (SNNs) offer three advantages:

1. **Temporal coding**: The time of a spike carries information, not just its presence -- analogous to how the timing of an epigenetic change matters, not just whether it occurred
2. **Event-driven computation**: SNNs only compute when input spikes arrive, matching the sparse, irregular sampling of longitudinal epigenomic data
3. **Hebbian learning**: Connections strengthen when pre- and post-synaptic neurons fire together -- analogous to how co-occurring epigenetic changes at different loci indicate shared regulatory control

### SNN Architecture for Epigenomic Pattern Detection

```
+-----------------------------------------------------------------------------+
|                    SPIKING NEURAL NETWORK ARCHITECTURE                        |
+-----------------------------------------------------------------------------+
|                                                                              |
|  INPUT LAYER: Epigenetic Event Encoding                                      |
|  +--------+  +--------+  +--------+  +--------+        +--------+           |
|  | CpG    |  | CpG    |  | H3K4me3|  | H3K27ac|  ...  | ATAC   |           |
|  | site 1 |  | site 2 |  | peak 1 |  | peak 1 |       | peak N |           |
|  | neuron |  | neuron |  | neuron |  | neuron |        | neuron |           |
|  +---+----+  +---+----+  +---+----+  +---+----+        +---+----+           |
|      |           |           |           |                  |                |
|      | spike when methylation/signal changes beyond threshold               |
|      |           |           |           |                  |                |
|  HIDDEN LAYER 1: Regulatory Element Detectors                                |
|  +------------+  +------------+  +------------+  +------------+             |
|  | Promoter   |  | Enhancer   |  | Insulator  |  | Silencer   |             |
|  | state      |  | state      |  | state      |  | state      |             |
|  | detector   |  | detector   |  | detector   |  | detector   |             |
|  +-----+------+  +-----+------+  +-----+------+  +-----+------+             |
|        |               |               |               |                     |
|  HIDDEN LAYER 2: Chromatin Domain Integrators                                |
|  +----------------+  +----------------+  +----------------+                  |
|  | TAD-level      |  | Compartment-   |  | Super-enhancer |                  |
|  | state tracker  |  | level (A/B)    |  | state tracker  |                  |
|  | (neuron group) |  | tracker        |  | (neuron group) |                  |
|  +-------+--------+  +-------+--------+  +-------+--------+                  |
|          |                    |                    |                          |
|  HIDDEN LAYER 3: Pathway / Gene Program Integrators                          |
|  +-------------------+  +-------------------+  +-------------------+         |
|  | Cell identity     |  | Stress response   |  | Aging pathway     |         |
|  | maintenance       |  | program           |  | activation        |         |
|  | program           |  |                   |  |                   |         |
|  +--------+----------+  +--------+----------+  +--------+----------+         |
|           |                      |                      |                    |
|  OUTPUT LAYER: Clinical Readouts                                             |
|  +-----------+  +-----------+  +-----------+  +-----------+                  |
|  | Bio-Age   |  | Cancer    |  | Neuro-    |  | Treatment |                  |
|  | change    |  | risk      |  | degeneration| | response  |                  |
|  | rate      |  | spike     |  | spike     |  | spike     |                  |
|  +-----------+  +-----------+  +-----------+  +-----------+                  |
|                                                                              |
+-----------------------------------------------------------------------------+
```

### Neuron Model: Leaky Integrate-and-Fire with Adaptation

Each SNN neuron follows the Leaky Integrate-and-Fire (LIF) model with spike-frequency adaptation:

```
Membrane potential dynamics:
  tau_m * dV/dt = -(V - V_rest) + R_m * I(t) - w(t)

Adaptation current dynamics:
  tau_w * dw/dt = a * (V - V_rest) - w

Spike condition:
  if V >= V_thresh:
    emit spike
    V <- V_reset
    w <- w + b  (adaptation increment)
```

Parameters:
- `tau_m` = 20 ms (membrane time constant)
- `V_rest` = -70 mV (resting potential)
- `V_thresh` = -50 mV (spike threshold)
- `V_reset` = -65 mV (post-spike reset)
- `R_m` = 100 MOhm (membrane resistance)
- `tau_w` = 200 ms (adaptation time constant)
- `a` = 2 nS (subthreshold adaptation coupling)
- `b` = 0.02 nA (spike-triggered adaptation increment)

**Temporal encoding of epigenetic events:**

Epigenetic changes at each CpG site or histone peak are encoded as input currents:

```
I_g(t) = alpha * (T[g, m, c, t] - T[g, m, c, t-1]) / delta_t
```

Where alpha is a gain factor calibrated so that the maximum biologically plausible rate of methylation change (~0.01 beta/year for age-related drift) produces a low firing rate (~1 Hz), and rapid changes during development or disease (~0.1 beta/month) produce high firing rates (~50 Hz).

### Neuromodulatory Signals

The SNN incorporates neuromodulatory signals that globally modify network dynamics, analogous to how systemic biological signals (hormones, inflammation) globally modulate the epigenome:

| Neuromodulator | Biological Analogue | Effect on SNN | Trigger |
|---------------|--------------------|--------------|---------|
| Dopamine (DA) | Reward / positive outcome | Increases synaptic plasticity (learning rate x2) | Treatment response detected |
| Serotonin (5-HT) | Homeostatic regulation | Stabilizes firing rates (adaptive threshold) | Steady-state epigenomic period |
| Norepinephrine (NE) | Stress / alerting | Increases sensitivity (lower threshold) | Rapid epigenomic changes detected |
| Acetylcholine (ACh) | Attention / focus | Sharpens receptive fields (increased lateral inhibition) | Specific locus under clinical scrutiny |

```rust
use ruvector_nervous_system::{SNN, NeuromodulatorSignal, Modulator};

let mut snn = SNN::new(snn_config);

// Inject neuromodulatory signal when rapid changes are detected
if methylation_change_rate > threshold_fast {
    snn.inject_modulator(NeuromodulatorSignal {
        modulator: Modulator::Norepinephrine,
        intensity: 0.8,        // Strong alerting signal
        duration_ms: 500.0,    // Sustained for 500 simulated ms
        target_layers: vec![0, 1],  // Affect input and first hidden layer
    })?;
}
```

### Hebbian Learning and STDP

Synaptic weights in the SNN are updated via spike-timing-dependent plasticity (STDP):

```
delta_w = {
  A_+ * exp(-|delta_t| / tau_+)  if t_post - t_pre > 0  (LTP: pre before post)
  -A_- * exp(-|delta_t| / tau_-)  if t_post - t_pre < 0  (LTD: post before pre)
}

where:
  delta_t = t_post - t_pre (time difference between post- and pre-synaptic spikes)
  A_+ = 0.01  (LTP amplitude)
  A_- = 0.012 (LTD amplitude, slightly stronger to maintain stability)
  tau_+ = 20 ms (LTP time constant)
  tau_- = 20 ms (LTD time constant)
```

**Biological interpretation**: When two CpG sites consistently change methylation state together (co-occurring spikes), the synapse strengthens (LTP), encoding the regulatory relationship. When changes are anti-correlated, the synapse weakens (LTD). This self-organizes the SNN into a network that reflects the true regulatory architecture of the epigenome.

```rust
use ruvector_nervous_system::{STDPRule, LearningConfig};

let stdp = STDPRule {
    a_plus: 0.01,
    a_minus: 0.012,
    tau_plus_ms: 20.0,
    tau_minus_ms: 20.0,
    w_max: 1.0,
    w_min: 0.0,
    // Homeostatic scaling: prevent runaway excitation
    homeostatic_target_rate_hz: 5.0,
    homeostatic_time_constant_s: 100.0,
};

let learning_config = LearningConfig {
    stdp_rule: stdp,
    // EWC++ integration: protect critical learned weights from catastrophic forgetting
    ewc_lambda: 100.0,       // Fisher information regularization strength
    ewc_gamma: 0.99,         // Online EWC decay factor
    // Weight consolidation every 1000 simulation steps
    consolidation_interval: 1000,
};

snn.configure_learning(learning_config)?;
```

---

## SONA Integration

### Self-Optimizing Neural Architecture for Patient-Specific Epigenomic Landscapes

SONA (Self-Optimizing Neural Architecture) provides real-time architecture adaptation with guaranteed <0.05ms latency. In the temporal epigenomic engine, SONA adapts the analysis pipeline to each patient's unique epigenomic trajectory.

### Adaptation Targets

| Component | What SONA Adapts | Adaptation Trigger | Latency |
|-----------|-----------------|-------------------|---------|
| Epigenetic clock | CpG site weights and temporal feature selection | New methylation observation | <0.05 ms |
| SNN topology | Neuron count, connectivity, layer depth | Epigenomic complexity change detected | <0.05 ms |
| Tensor decomposition | Rank selection (R1, R2, R3, R4) per patient | Reconstruction error exceeds threshold | <0.05 ms |
| Delta encoding | Epsilon threshold per data type per patient | Compression ratio drops below target | <0.05 ms |
| Query routing | Which decomposed factor path to use | Query pattern frequency changes | <0.05 ms |

### Patient-Specific Clock Adaptation

Standard epigenetic clocks use population-level weights. SONA personalizes clock weights using Bayesian online updating:

```
w_patient(t+1) = w_patient(t) + eta * (y_observed - y_predicted) * x(t) / (||x(t)||^2 + lambda)
```

Where:
- `w_patient` = patient-specific CpG weights (initialized from population model)
- `eta` = learning rate (SONA-adapted, typically 0.001-0.01)
- `y_observed` = known chronological age or clinical outcome
- `y_predicted` = clock prediction
- `x(t)` = CpG feature vector at time t
- `lambda` = regularization toward population weights (prevents overfitting with few time points)

**EWC++ protection**: When adapting to a new patient, SONA uses Elastic Weight Consolidation (Kirkpatrick et al., 2017) with online Fisher information to prevent catastrophic forgetting of population-level patterns:

```
L_total = L_patient + (lambda_ewc / 2) * sum_i F_i * (w_i - w_i*)^2

where:
  L_patient = patient-specific loss
  F_i = diagonal Fisher information for weight i (accumulated online)
  w_i* = consolidated population weight for parameter i
  lambda_ewc = 100 (regularization strength)
```

### Continuous Learning Protocol

```rust
use sona::{SonaAdapter, AdaptationConfig, EWCConfig};

let sona = SonaAdapter::new(AdaptationConfig {
    max_latency_ms: 0.05,   // Hard guarantee: <0.05ms per adaptation step
    learning_rate: 0.005,
    adaptation_window: 10,    // Consider last 10 observations
    ewc: EWCConfig {
        lambda: 100.0,
        gamma: 0.99,          // Online Fisher decay
        consolidation_after: 50,  // Consolidate after 50 patient observations
    },
});

// On each new methylation observation:
let adaptation_result = sona.adapt(
    &current_model_weights,
    &new_observation,
    &patient_history,
)?;
// adaptation_result.latency_ms: 0.03  (within budget)
// adaptation_result.weights_updated: 47 of 1030 CpG weights
// adaptation_result.clock_improvement_mae: -0.2 years (reduced error)
// adaptation_result.ewc_regularization_loss: 0.001 (minimal deviation from population model)
```

### Architecture Search under Latency Constraints

SONA performs neural architecture search (NAS) for the SNN component, optimizing:

```
maximize: prediction_accuracy(SNN_topology)
subject to:
  inference_latency(SNN_topology) < 0.05 ms
  memory_usage(SNN_topology) < 50 MB per patient
  |SNN_topology.neuron_count| in [100, 10_000]
  |SNN_topology.layer_count| in [2, 6]
```

The search uses a one-shot NAS supernet with weight sharing (Pham et al., 2018), adapted for SNNs. The supernet contains all possible architectures as subgraphs; SONA samples and evaluates candidate architectures using an evolutionary strategy with O(1) evaluation cost per candidate.

**Typical adapted architectures per patient profile:**

| Patient Profile | Neurons | Layers | Key Feature |
|----------------|---------|--------|-------------|
| Healthy aging, dense time points | 500 | 3 | Standard architecture |
| Cancer patient, rapid changes | 2,000 | 4 | Extra layer for multi-scale dynamics |
| Pediatric, developmental transitions | 1,500 | 4 | Bivalent promoter specialist neurons |
| Elderly, sparse observations | 200 | 2 | Minimal architecture, strong priors |
| Multi-tissue longitudinal study | 5,000 | 5 | Cross-tissue integration layer |

---

## Clinical Applications

### 1. Cancer Early Detection

**Mechanism**: Tumors exhibit characteristic DNA methylation changes years before clinical presentation:
- Global hypomethylation (LINE-1, Alu repeats lose methylation)
- CpG island hypermethylation at tumor suppressor gene promoters (BRCA1, MLH1, CDKN2A, VHL)
- Enhancer reprogramming (gain of H3K4me1/H3K27ac at oncogenic super-enhancers)

**Temporal signature**: The engine detects the transition from stochastic age-related drift to directed tumor-associated methylation changes:

```
Cancer Risk Score = f(
    methylation_acceleration_at_suppressor_promoters,  // above-expected methylation gain
    LINE1_demethylation_rate,                          // accelerated repeat hypomethylation
    enhancer_turnover_rate,                            // rate of enhancer gain/loss events
    cell_type_composition_shift,                       // clonal expansion signal
    H3K27me3_redistribution_rate                       // Polycomb domain disruption
)
```

**Detection timeline:**

| Cancer Type | Earliest Epigenomic Signal | Lead Time Before Diagnosis | Key CpG Regions |
|-------------|--------------------------|---------------------------|-----------------|
| Colorectal | MLH1 promoter hypermethylation, SEPT9 methylation | 2-5 years | MLH1, SEPT9, VIM, NDRG4 |
| Breast | BRCA1 promoter hypermethylation, ESR1 regulatory changes | 1-3 years | BRCA1, RASSF1A, APC, ESR1 |
| Lung | CDKN2A (p16) silencing, SHOX2/PTGER4 methylation | 1-4 years | CDKN2A, SHOX2, PTGER4, RASSF1A |
| Hepatocellular | Global hypomethylation, AFP regulatory activation | 2-6 years | AFP enhancer, IGF2/H19 ICR |
| Hematologic (MDS/AML) | TET2/DNMT3A mutation-associated methylation shift | 5-10 years (clonal hematopoiesis) | HOXA cluster, CEBPA, EVI1 |

### 2. Neurodegeneration Prediction

**Mechanism**: Neurodegenerative diseases (Alzheimer, Parkinson, ALS) are preceded by epigenomic changes in both brain tissue and peripheral blood:

- Alzheimer: Hypermethylation of ANK1, BIN1, and HOXA3 in dorsolateral prefrontal cortex; detectable in blood as altered H3K4me3 at APOE regulatory region
- Parkinson: Hypomethylation of SNCA intron 1 (increasing alpha-synuclein expression); altered ATAC-seq at dopaminergic gene loci
- ALS: Hypermethylation of C9orf72 repeat expansion region; altered methylation at SOD1 and FUS regulatory elements

**Temporal tensor features for neurodegeneration risk:**

```rust
let neuro_features = TemporalQuery::new()
    .genome_predicate(|g| is_neurodegeneration_locus(g))
    .marks(&[Mark::CpG5mC, Mark::H3K4me3, Mark::H3K27me3, Mark::ATACseq])
    .cell_types(&[CellType::WholeBlood, CellType::Monocyte, CellType::NeuronDerived])
    .time_range(TimeRange::LastYears(5))
    .aggregate(AggregationOp::TemporalDerivative)  // Rate of change
    .build();

let risk_features = tensor.query(&neuro_features)?;

// Feed into SNN for pattern detection
let neuro_risk = snn.evaluate(&risk_features)?;
// NeuroRisk {
//     alzheimer_risk_5yr: 0.12,        // 12% 5-year risk
//     parkinson_risk_5yr: 0.03,
//     als_risk_5yr: 0.001,
//     confidence: 0.85,
//     key_loci: [("ANK1", -0.3), ("BIN1", -0.2), ("APOE", 0.1)],
//     recommended_monitoring_interval: Duration::from_months(6),
// }
```

### 3. Fetal Epigenomic Monitoring

**Mechanism**: Cell-free fetal DNA (cffDNA) in maternal blood carries methylation patterns from placental trophoblasts. Temporal monitoring of cffDNA methylation enables non-invasive detection of:

- Imprinting disorders (Beckwith-Wiedemann, Angelman, Prader-Willi syndrome)
- Preeclampsia risk (altered methylation at RASSF1, SERPINB5, TBX3 in placental DNA)
- Intrauterine growth restriction (IUGR) via IGF2/H19 imprinting changes
- Gestational diabetes impact on fetal methylation programming

**Temporal monitoring protocol:**

| Gestational Week | Assay | Key Targets | Detectable Conditions |
|-----------------|-------|-------------|----------------------|
| 10-12 | cffDNA methylation (targeted) | H19/IGF2 ICR, RASSF1A, SERPINB5 | Imprinting disorders, trisomy confirmation |
| 16-20 | cffDNA methylation (genome-wide) | Placental-specific DMRs, growth factor loci | IUGR risk, preeclampsia risk |
| 24-28 | cffDNA methylation + maternal blood | HIF1A, VEGF regulatory regions, glucocorticoid receptor | Preeclampsia progression, GDM impact |
| 32-36 | cffDNA methylation (targeted follow-up) | Patient-specific risk loci identified at earlier time points | Confirmation, intervention monitoring |

**Delta encoding advantage**: Between gestational weeks, fetal epigenomic changes are small (<3% of monitored CpG sites change beyond threshold per week), making delta encoding extremely efficient. A full gestational monitoring dataset (10 time points x 450K CpG sites) compresses from approximately 18 MB (dense) to approximately 2 MB (delta-encoded).

### 4. Aging Intervention Response Tracking

**Real-time dashboard metrics:**

```
+----------------------------------------------------------------------+
| EPIGENOMIC INTERVENTION TRACKER                                       |
| Patient: P-2026-0042    Intervention: Caloric Restriction (25%)       |
| Started: 2025-08-01     Current: 2026-02-11 (6 months)               |
+----------------------------------------------------------------------+
|                                                                       |
| BIOLOGICAL AGE        PACE OF AGING        AGE ACCELERATION           |
|   Before: 58.2 yr      Before: 1.12 yr/yr   Before: +4.2 yr         |
|   Current: 56.8 yr     Current: 0.94 yr/yr   Current: +2.8 yr       |
|   Delta: -1.4 yr       Delta: -0.18 yr/yr    Delta: -1.4 yr         |
|   p-value: 0.003       p-value: 0.01         p-value: 0.003         |
|                                                                       |
| COMPONENT CHANGES (sorted by effect magnitude):                       |
|   Metabolic aging:        -0.8 yr  [=======>          ] 57% of effect|
|   Inflammatory aging:     -0.3 yr  [===>              ] 21% of effect|
|   Immunosenescent aging:  -0.2 yr  [==>               ] 14% of effect|
|   Replicative aging:      -0.1 yr  [=>                ]  7% of effect|
|   Polycomb erosion:        0.0 yr  [                  ]  0% of effect|
|   Stochastic drift:        0.0 yr  [                  ]  0% of effect|
|                                                                       |
| TOP RESPONSIVE CpG SITES:                                             |
|   1. cg06500161 (IGF1 promoter): beta -0.08 (p=0.001)               |
|   2. cg16867657 (FOXO3 exon 2):  beta -0.06 (p=0.002)              |
|   3. cg00574958 (SIRT1 enhancer): beta -0.05 (p=0.005)             |
|   4. cg07553761 (mTOR promoter): beta +0.04 (p=0.01)               |
|   5. cg03546163 (AMPK regulatory): beta -0.04 (p=0.012)            |
|                                                                       |
| RECOMMENDED NEXT MEASUREMENT: 2026-05-11 (3 months)                  |
+----------------------------------------------------------------------+
```

---

## Performance Targets

### Temporal Query Latencies

| Query Type | Tensor Size | Latency Target | Implementation Strategy |
|-----------|-------------|---------------|----------------------|
| Single locus, single mark, full timeline | 1 CpG x 1 mark x 1 cell type x 1000 time points | < 0.1 ms | Direct delta-frame traversal |
| Gene-level (100 CpGs), single mark, full timeline | 100 CpGs x 1 mark x 1 cell type x 1000 time points | < 1 ms | Delta-frame batch retrieval |
| Genome-wide summary, single time point | 28M CpGs x 14 marks x 1 cell type x 1 time point | < 50 ms | Decomposed factor lookup |
| Genome-wide trajectory, 10 time points | 28M CpGs x 14 marks x 1 cell type x 10 time points | < 200 ms | Decomposed factor + delta correction |
| Cross-tissue comparison, single locus | 1 CpG x 14 marks x 50 cell types x 1 time point | < 0.5 ms | Cell-type factor matrix lookup |
| Epigenetic clock computation (full) | 1030 CpGs x 1 mark x 1 cell type x all time points | < 5 ms | Precomputed CpG subset index |
| Intervention effect calculation | 1030 CpGs x 1 mark x 1 cell type x 2 time points + NMF | < 20 ms | Cached NMF factors, delta update |
| SNN inference (full network, 2000 neurons) | 2000 neurons x 1000 simulation steps | < 10 ms | Event-driven simulation, sparse connectivity |
| SONA adaptation step | Model weights update | < 0.05 ms | Guaranteed by SONA architecture |
| Full patient report generation | All queries + visualization prep | < 500 ms | Pipelined query execution |

### Storage per Patient-Year

| Data Type | Raw Size per Observation | Observations per Year | Raw per Year | Delta-Compressed per Year |
|-----------|-------------------------|----------------------|-------------|--------------------------|
| EPIC array (450K CpGs) | 1.7 MB | 2-4 | 3.4-6.8 MB | 0.5-1.0 MB |
| WGBS (28M CpGs) | 106 MB | 1-2 | 106-212 MB | 10-20 MB |
| ChIP-seq (6 marks, peaks) | 50 MB per mark | 1-2 per mark | 300-600 MB | 40-80 MB |
| ATAC-seq (accessibility peaks) | 30 MB | 1-2 | 30-60 MB | 5-10 MB |
| Decomposed factors (patient-specific) | 10 MB (one-time) | Updated per observation | 10 MB + 0.5 MB/update | N/A (already compressed) |
| SNN weights (patient-specific) | 2 MB | Continuously updated | 2 MB + 0.1 MB/update | N/A |
| Clock history + intervention tracking | 0.1 MB per observation | 2-4 | 0.2-0.4 MB | 0.2-0.4 MB |

**Total per patient-year (EPIC array, typical clinical):** approximately 1-2 MB delta-compressed
**Total per patient-year (multi-omic research):** approximately 60-120 MB delta-compressed

**Population-scale storage projections:**

| Scale | Patients | Years of Data | Storage (EPIC clinical) | Storage (Multi-omic) |
|-------|---------|--------------|------------------------|---------------------|
| Single institution | 10K | 5 | 50-100 GB | 3-6 TB |
| National biobank | 1M | 10 | 10-20 TB | 600 TB - 1.2 PB |
| Global consortium | 100M | 20 | 2-4 PB | 120-240 PB |

### Real-Time Streaming Performance

| Metric | Target | Implementation |
|--------|--------|---------------|
| New observation ingestion latency | < 100 ms | Delta encoding + tensor index update |
| Streaming tensor decomposition update | < 200 ms per new time point | Online Tucker decomposition |
| Clock re-estimation after new data | < 5 ms | SONA-adapted weight application |
| SNN re-simulation with new input | < 10 ms | Event-driven, only affected neurons re-simulated |
| Alert generation (cancer risk threshold exceeded) | < 50 ms | Pre-computed threshold comparison |
| Full patient report refresh | < 500 ms | Pipelined query execution |
| Concurrent patient streams | >= 1,000 | Sharded tensor storage, per-patient SONA instances |

---

## Implementation Architecture

### Crate Dependencies

```
ruvector-temporal-epigenomic-engine
  |
  +-- ruvector-temporal-tensor       (4D sparse tensor with temporal indexing)
  |     +-- SparseTensor4D           (COO-format 4D tensor with delta compression)
  |     +-- TuckerDecomposition      (streaming Tucker decomposition)
  |     +-- TemporalQuery            (temporal query algebra)
  |     +-- DeltaIterator            (iterate over delta frames)
  |
  +-- ruvector-delta-core            (delta-encoded storage engine)
  |     +-- DeltaStore               (base frame + delta frame storage)
  |     +-- DeltaCompressor          (epsilon-based change detection)
  |     +-- DeltaValue               (quantized delta types)
  |     +-- SnapshotReconstructor    (reconstruct any time point from base + deltas)
  |
  +-- ruvector-nervous-system        (spiking neural network engine)
  |     +-- SNN                      (spiking neural network)
  |     +-- LIFNeuron                (leaky integrate-and-fire neuron model)
  |     +-- STDPRule                 (spike-timing-dependent plasticity)
  |     +-- NeuromodulatorSignal     (neuromodulatory signal injection)
  |     +-- EventDrivenSimulator     (sparse event-driven SNN simulation)
  |
  +-- sona                           (self-optimizing neural architecture)
  |     +-- SonaAdapter              (<0.05ms adaptation)
  |     +-- EWCRegularizer           (elastic weight consolidation ++)
  |     +-- NASController            (neural architecture search under latency constraints)
  |     +-- PatientModel             (per-patient model state)
  |
  +-- ruvector-core                  (HNSW for CpG similarity search)
        +-- HnswIndex               (nearest-neighbor CpG lookup)
        +-- DistanceMetric           (cosine/euclidean for methylation vectors)
```

### Rust Module Structure

```rust
// crates/ruvector-temporal-epigenomic-engine/src/lib.rs

pub mod tensor {
    pub mod sparse4d;           // 4D sparse tensor implementation
    pub mod delta;              // Delta encoding/decoding
    pub mod decomposition;      // Tucker decomposition (batch + streaming)
    pub mod query;              // Temporal query algebra
    pub mod reconstruction;     // Time-point reconstruction from deltas
}

pub mod clock {
    pub mod multi_tissue;       // Multi-tissue epigenetic clock
    pub mod phenoage;           // Biological age (PhenoAge-Temporal)
    pub mod pace;               // Pace of aging (DunedinPACE-Temporal)
    pub mod components;         // NMF-based aging component decomposition
    pub mod intervention;       // Intervention effect tracking
    pub mod calibration;        // Clock calibration against truth cohorts
}

pub mod nervous {
    pub mod snn;                // Spiking neural network architecture
    pub mod neuron;             // LIF neuron model with adaptation
    pub mod stdp;               // Spike-timing-dependent plasticity
    pub mod neuromodulation;    // Neuromodulatory signal system
    pub mod topology;           // Network topology (regulatory element -> pathway)
    pub mod encoding;           // Epigenetic event -> spike encoding
}

pub mod sona_integration {
    pub mod adapter;            // SONA adapter for epigenomic models
    pub mod patient_model;      // Per-patient model state management
    pub mod architecture_search; // NAS for SNN topology
    pub mod ewc;                // EWC++ for catastrophic forgetting prevention
}

pub mod clinical {
    pub mod cancer;             // Cancer early detection module
    pub mod neurodegeneration;  // Neurodegeneration prediction
    pub mod fetal;              // Fetal epigenomic monitoring
    pub mod aging;              // Aging intervention tracking
    pub mod report;             // Clinical report generation
    pub mod alerts;             // Real-time alert system
}

pub mod streaming {
    pub mod ingestion;          // New observation ingestion
    pub mod pipeline;           // Streaming analysis pipeline
    pub mod checkpoint;         // State checkpointing
}
```

### Data Flow

```
    Methylation Array / WGBS / ChIP-seq / ATAC-seq Input
                          |
                          v
              +-----------------------+
              | Observation Ingestion |
              | - QC filtering        |
              | - Normalization       |
              | - Cell-type deconvol. |
              +-----------+-----------+
                          |
              +-----------v-----------+
              | Delta Encoding        |
              | (ruvector-delta-core) |
              | - Diff against prev.  |
              | - Epsilon thresholding|
              | - Quantized storage   |
              +-----------+-----------+
                          |
          +---------------+---------------+
          |               |               |
          v               v               v
   +------+------+ +-----+------+ +------+------+
   | Temporal    | | SNN        | | SONA        |
   | Tensor      | | Simulation | | Adaptation  |
   | Update      | | (ruvector- | | (<0.05ms)   |
   | (decomp.)   | | nervous-   | |             |
   |             | | system)    | |             |
   +------+------+ +-----+------+ +------+------+
          |               |               |
          v               v               v
   +------+------+ +-----+------+ +------+------+
   | Epigenetic  | | Temporal   | | Patient-    |
   | Clock       | | Pattern    | | Specific    |
   | Computation | | Detection  | | Model       |
   |             | | (STDP-     | | Update      |
   |             | |  learned)  | |             |
   +------+------+ +-----+------+ +------+------+
          |               |               |
          +-------+-------+-------+-------+
                  |
                  v
          +-------+--------+
          | Clinical       |
          | Application    |
          | Router         |
          +--+--+--+--+---+
             |  |  |  |
             v  v  v  v
          Cancer  Neuro  Fetal  Aging
          Detection  Pred.  Monitor  Track
                  |
                  v
          +-------+--------+
          | Alert Engine    |
          | + Report Gen.   |
          +----------------+
```

---

## Consequences

### Positive Consequences

1. **Longitudinal epigenomic analysis**: First system to natively model epigenomic changes over time as a continuous process rather than independent snapshots
2. **Extreme storage efficiency**: Delta encoding achieves 50-200x compression for slowly changing epigenomic data, enabling population-scale longitudinal storage
3. **Biologically inspired computation**: Spiking neural networks with Hebbian learning self-organize to mirror the regulatory structure of the epigenome, providing interpretable intermediate representations
4. **Patient-specific precision**: SONA adaptation personalizes epigenetic clock models within <0.05ms, improving age estimation accuracy as more longitudinal data accumulates
5. **Multi-scale temporal resolution**: The tensor decomposition naturally supports queries at multiple temporal resolutions, from hours (histone acetylation dynamics) to decades (aging trajectories)
6. **Clinical actionability**: Direct integration with cancer detection, neurodegeneration prediction, fetal monitoring, and aging intervention tracking provides immediate clinical utility

### Negative Consequences

1. **Data acquisition cost**: Full multi-omic longitudinal profiling (WGBS + 6 ChIP-seq marks + ATAC-seq per time point) costs approximately $5,000-10,000 per observation; clinical deployment may be limited to targeted arrays ($200-500 per observation)
2. **Deconvolution uncertainty**: Cell-type deconvolution from bulk tissue introduces noise in the cell-type axis; single-cell methods reduce this but increase cost 10-100x
3. **Sparse temporal sampling**: Most longitudinal cohorts have 2-10 time points per patient, limiting the temporal resolution of pattern detection; interpolation between observations introduces model-dependent bias
4. **SNN computational cost**: Full SNN simulation with STDP learning is 5-10x more expensive than equivalent ANN processing; mitigated by event-driven simulation and sparse connectivity
5. **Epigenetic clock validation**: Patient-specific clock adaptation requires longitudinal ground truth (known outcomes) that may take years to accumulate

### Risk Mitigation

| Risk | Probability | Impact | Mitigation |
|------|------------|--------|------------|
| Delta encoding loses clinically significant small changes | Medium | High | Adaptive epsilon per CpG: lower threshold at known disease-associated sites; validation against uncompressed data on benchmark cohorts |
| SNN fails to learn meaningful temporal patterns with sparse data | Medium | Medium | Pre-train SNN on synthetic data from known epigenetic dynamics models; transfer learning from large research cohorts |
| SONA adaptation overfits to patient noise | Low | Medium | EWC++ regularization toward population model; minimum 3 observations before adaptation activates |
| Tensor decomposition rank too low for complex patients | Low | Low | Adaptive rank selection monitored by reconstruction error; fallback to full sparse tensor for complex cases |
| Epigenetic clock drifts from ground truth over long monitoring periods | Medium | Medium | Periodic recalibration against chronological age; anchoring observations at known health events |
| Cross-platform methylation array differences (450K vs EPIC vs EPICv2) | High | Medium | Intersection CpG set for clock computation; platform-specific normalization in ingestion layer |

---

## References

1. Horvath, S. (2013). "DNA methylation age of human tissues and cell types." *Genome Biology*, 14(10), R115. (Multi-tissue epigenetic clock, 353 CpG sites.)

2. Lu, A.T., et al. (2019). "DNA methylation GrimAge strongly predicts lifespan and healthspan." *Aging*, 11(2), 303-327. (GrimAge clock, mortality-adjusted.)

3. Belsky, D.W., et al. (2022). "DunedinPACE, a DNA methylation biomarker of the pace of aging." *eLife*, 11, e73420. (Pace of aging estimation.)

4. Roadmap Epigenomics Consortium (2015). "Integrative analysis of 111 reference human epigenomes." *Nature*, 518, 317-330. (Reference epigenomes, histone mark catalog.)

5. Buenrostro, J.D., et al. (2013). "Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position." *Nature Methods*, 10(12), 1213-1218. (ATAC-seq.)

6. Ernst, J., & Kellis, M. (2012). "ChromHMM: automating chromatin-state discovery and characterization." *Nature Methods*, 9(3), 215-216. (Chromatin state modeling.)

7. Kirkpatrick, J., et al. (2017). "Overcoming catastrophic forgetting in neural networks." *PNAS*, 114(13), 3521-3526. (Elastic Weight Consolidation.)

8. Maass, W. (1997). "Networks of spiking neurons: the third generation of neural network models." *Neural Networks*, 10(9), 1659-1671. (Spiking neural networks.)

9. Bi, G., & Poo, M. (1998). "Synaptic modifications in cultured hippocampal neurons: dependence on spike timing, synaptic strength, and postsynaptic cell type." *Journal of Neuroscience*, 18(24), 10464-10472. (STDP.)

10. Kasiviswanathan, S.P., et al. (2011). "Online tensor decomposition." *NIPS Workshop on Tensors, Kernels, and Machine Learning*. (Streaming Tucker decomposition.)

11. Levine, M.E., et al. (2018). "An epigenetic biomarker of aging for lifespan and healthspan." *Aging*, 10(4), 573-591. (PhenoAge.)

12. Teschendorff, A.E. (2020). "A comparison of epigenetic mitotic-like clocks for cancer risk prediction." *Genome Medicine*, 12, 56. (Epigenetic clock comparison for cancer.)

13. De Jager, P.L., et al. (2014). "Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci." *Nature Neuroscience*, 17, 1156-1163. (Neurodegeneration methylation signatures.)

14. Pham, H., et al. (2018). "Efficient neural architecture search via parameter sharing." *ICML 2018*. (One-shot NAS.)

15. Kolmogorov, V., & Zabih, R. (2004). "What energy functions can be minimized via graph cuts?" *IEEE TPAMI*, 26(2), 147-159. (Tensor decomposition foundations.)

---

## Related Decisions

- **ADR-001**: RuVector Core Architecture (HNSW index, SIMD distance)
- **ADR-003**: Hierarchical Navigable Small World Genomic Vector Index (epigenetic state vectors as one of six genomic vector spaces)
- **ADR-009**: Zero-False-Negative Variant Calling Pipeline (variant calls that trigger epigenomic monitoring)

---

## Revision History

| Version | Date | Author | Changes |
|---------|------|--------|---------|
| 0.1 | 2026-02-11 | RuVector DNA Analyzer Team | Initial proposal |
